Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors

NCT00116896 is registered in ClinicalTrials.gov with OSI Pharmaceuticals as lead sponsor.

NCT NCT00116896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors
Lead sponsor
OSI Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2003
Completion date
December 31, 2004
Enrollment
25
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors